Amino acids in cancer

EL Lieu, T Nguyen, S Rhyne, J Kim - Experimental & molecular …, 2020 - nature.com
Abstract Over 90 years ago, Otto Warburg's seminal discovery of aerobic glycolysis
established metabolic reprogramming as one of the first distinguishing characteristics of …

The Warburg effect 97 years after its discovery

RM Pascale, DF Calvisi, MM Simile, CF Feo, F Feo - Cancers, 2020 - mdpi.com
Simple Summary The deregulation of the oxidative metabolism in cancer cells,
characterized by an increased ratio between glycolysis and oxygen consumption (Warburgv …

[HTML][HTML] Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma

Q Gao, H Zhu, L Dong, W Shi, R Chen, Z Song… - Cell, 2019 - cell.com
We performed the first proteogenomic characterization of hepatitis B virus (HBV)-related
hepatocellular carcinoma (HCC) using paired tumor and adjacent liver tissues from 159 …

The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma

S Xia, Y Pan, Y Liang, J Xu, X Cai - EBioMedicine, 2020 - thelancet.com
In most cases, sorafenib-resistant HCC cells exhibit significant mesenchymal phenotype and
stemness features. In this context, tumor cells might undergo cell fate transition in response …

Glutamine metabolism in breast cancer and possible therapeutic targets

S Li, H Zeng, J Fan, F Wang, C Xu, Y Li, J Tu… - Biochemical …, 2023 - Elsevier
Cancer is characterized by metabolic reprogramming, which is a hot topic in tumor treatment
research. Cancer cells alter metabolic pathways to promote their growth, and the common …

The Janus-like role of proline metabolism in cancer

L Burke, I Guterman, R Palacios Gallego… - Cell death …, 2020 - nature.com
The metabolism of the non-essential amino acid L-proline is emerging as a key pathway in
the metabolic rewiring that sustains cancer cells proliferation, survival and metastatic …

Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities

S De Matteis, A Ragusa, G Marisi… - Oxidative medicine …, 2018 - Wiley Online Library
Hepatocellular carcinoma (HCC) accounts for over 80% of liver cancer cases and is highly
malignant, recurrent, drug‐resistant, and often diagnosed in the advanced stage. It is clear …

New advances in tissue metabolomics: a review

M Saoi, P Britz-McKibbin - Metabolites, 2021 - mdpi.com
Metabolomics offers a hypothesis-generating approach for biomarker discovery in clinical
medicine while also providing better understanding of the underlying mechanisms of chronic …

The proline cycle as a potential cancer therapy target

JJ Tanner, SM Fendt, DF Becker - Biochemistry, 2018 - ACS Publications
Interest in how proline contributes to cancer biology is expanding because of the emerging
role of a novel proline metabolic cycle in cancer cell survival, proliferation, and metastasis …

Proline metabolism in tumor growth and metastatic progression

C D'Aniello, EJ Patriarca, JM Phang… - Frontiers in oncology, 2020 - frontiersin.org
Cancer cells show a formidable capacity to survive under stringent conditions, to elude
mechanisms of control, such as apoptosis, and to resist therapy. Cancer cells reprogram …